Caffeic acid phenethyl ester as a protective agent against nephrotoxicity and/or oxidative kidney damage: A detailed systematic review

Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Akyol, Sumeyya ^a,b   Ugurcu, Veli ^c   Altuntas, Aynur ^d   Hasgul, Rukiye ^a   Cakmak, Ozlem ^e   Akyol, Omer ^d,f  

^a TURGUT OZAL UNIVERSITY   (Turkey)

^b GAZIOSMANPASA UNIVERSITY   (Turkey)

^c Private Bilecik Orhangazi Dialysis Center   (Turkey)

^d Ankara Branch of Council of Forensic Medicine   (Turkey)

^e GAZI UNIVERSITY   (Turkey)

^f HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CADMIUM; CAFFEIC ACID PHENETHYL ESTER; CARBON TETRACHLORIDE; CISPLATIN; CONTRAST MEDIUM; CYCLOSPORIN; CYCLOSPORIN A; DOXORUBICIN; GENTAMICIN; METHOTREXATE; TOLUENE; VANCOMYCIN; ANTINEOPLASTIC AGENT; ANTIOXIDANT; CAFFEIC ACID DERIVATIVE; PHENETHYL ALCOHOL;

AGING; DRUG CYTOTOXICITY; EXTRACORPOREAL LITHOTRIPSY; HUMAN; KIDNEY DISEASE; KIDNEY INJURY; NEPHROTOXICITY; OXIDATIVE STRESS; RENAL PROTECTION; REPERFUSION INJURY; REVIEW; SENILITY; SYSTEMATIC REVIEW; THERMAL INJURY; TOBACCO; ACUTE KIDNEY INJURY; ANALOGS AND DERIVATIVES; ANIMAL; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS;

ACUTE KIDNEY INJURY; ANIMALS; ANTINEOPLASTIC AGENTS; ANTIOXIDANTS; CAFFEIC ACIDS; HUMANS; OXIDATIVE STRESS; PHENYLETHYL ALCOHOL;

EID: 84903648273     PISSN: 23566140     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2014/561971     Document Type: Review

References (109)

1. Burdock G. A., Review of the biological properties and toxicity of bee propolis (propolis). Food and Chemical Toxicology 1998 36 4 347 363 2-s2.0-0032489791 10.1016/S0278-6915(97)00145-2 (Pubitemid 28255348)
2. Sud'ina G. F., Mirzoeva O. K., Pushkareva M. A., Korshunova G. A., Sumbatyan N. V., Varfolomeev S. D., Caffeic acid phenethyl ester as a lipoxygenase inhibitor with antioxidant properties. FEBS Letters 1993 329 1-2 21 24 2-s2.0-0027169199 10.1016/0014-5793(93)80184-V (Pubitemid 23248240)
3. Watabe M., Hishikawa K., Takayanagi A., Shimizu N., Nakaki T., Caffeic acid phenethyl ester induces apoptosis by inhibition of NF B and activation of Fas in human breast cancer MCF-7 cells. Journal of Biological Chemistry 2004 279 7 6017 6026 2-s2.0-1242294398 10.1074/jbc.M306040200 (Pubitemid 38220634)
4. McEleny K., Coffey R., Morrissey C., Fitzpatrick J. M., Watson R. W. G., Caffeic acid phenethyl ester-induced PC-3 cell apoptosis is caspase-dependent and mediated through the loss of inhibitors of apoptosis proteins. BJU International 2004 94 3 402 406 2-s2.0-4344569634 10.1111/j.1464-410X.2004. 04936.x (Pubitemid 39120188)
5. Gurel A., Armutcu F., Sahin S., Sogut S., Ozyurt H., Gulec M., Kutlu N. O., Akyol O., Protective role of α -tocopherol and caffeic acid phenethyl ester on ischemia-reperfusion injury via nitric oxide and myeloperoxidase in rat kidneys. Clinica Chimica Acta 2004 339 1-2 33 41 2-s2.0-0346996438 10.1016/j.cccn.2003.09.013 (Pubitemid 37542455)
6. Özyurt H., Kemal Irmak M., Akyol Ö., Söüt S., Caffeic acid phenethyl ester changes the indices of oxidative stress in serum of rats with renal ischaemia-reperfusion injury. Cell Biochemistry and Function 2001 19 4 259 263 2-s2.0-0035192705 10.1002/cbf.923 (Pubitemid 33097881)
7. Özen S., Akyol Ö., Iraz M., Söüt S., Özuurlu F., Özyurt H., Odaci E., Yildirim Z., Role of caffeic acid phenethyl ester, an active component of propolis, against cisplatin-induced nephrotoxicity in rats. Journal of Applied Toxicology 2004 24 1 27 35 2-s2.0-0442326350 10.1002/jat.941 (Pubitemid 38185778)
8. Yagmurca M., Erdogan H., Iraz M., Songur A., Ucar M., Fadillioglu E., Caffeic acid phenethyl ester as a protective agent against doxorubicin nephrotoxicity in rats. Clinica Chimica Acta 2004 348 1-2 27 34 2-s2.0-4444337991 10.1016/j.cccn.2004.03.035 (Pubitemid 39208997)
9. Grunberger D., Banerjee R., Eisinger K., Oltz E. M., Efros L., Caldwell M., Estevez V., Nakanishi K., Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis. Experientia 1988 44 3 230 232 2-s2.0-0023838394 10.1007/BF01941717 (Pubitemid 18066629)
10. Akyol S., Ginis Z., Armutcu F., Ozturk G., Yigitoglu M. R., Akyol O., The potential usage of caffeic acid phenethyl ester (CAPE) against chemotherapy-induced and radiotherapy-induced toxicity. Cell Biochemistry and Function 2012 30 5 438 443 2-s2.0-84863306204 10.1002/cbf.2817
11. Tolba M. F., Esmat A., Al-Abd A. M., Caffeic acid phenethyl ester synergistically enhances docetaxel and paclitaxel cytotoxicity in prostate cancer cells. IUBMB Life 2013 65 716 729
12. Chiao C., Carothers A. M., Grunberger D., Solomon G., Preston G. A., Barrett J. C., Apoptosis and altered redox state induced by caffeic acid phenethyl ester (CAPE) in transformed rat fibroblast cells. Cancer Research 1995 55 16 3576 3583 2-s2.0-0029130189
13. Lee Y.-J., Liao P.-H., Chen W.-K., Yang C.-C., Preferential cytotoxicity of caffeic acid phenethyl ester analogues on oral cancer cells. Cancer Letters 2000 153 1-2 51 56 2-s2.0-0034729308 10.1016/S0304-3835(00)00389-X (Pubitemid 30209842)
14. Chen Y.-J., Shiao M.-S., Wang S.-Y., The antioxidant caffeic acid phenethyl ester induces apoptosis associated with selective scavenging of hydrogen peroxide in human leukemic HL-60 cells. Anti-Cancer Drugs 2001 12 2 143 149 2-s2.0-0035097459 10.1097/00001813-200102000-00008 (Pubitemid 32207364)
15. Guarini L., Su -z. Z., Zucker S., Lin J., Grunberger D., Fisher P. B., Growth inhibition and modulation of antigenic phenotype in human melanoma and glioblastoma multiforme cells by caffeic acid phenethyl ester (CAPE). Cellular and Molecular Biology 1992 38 5 513 527 2-s2.0-0026484223
16. Lee Y.-J., Kuo H.-C., Chu C.-Y., Wang C.-J., Lin W.-C., Tseng T.-H., Involvement of tumor suppressor protein p53 and p38 MAPK in caffeic acid phenethyl ester-induced apoptosis of C6 glioma cells. Biochemical Pharmacology 2003 66 12 2281 2289 2-s2.0-0344585942 10.1016/j.bcp.2003.07.014 (Pubitemid 37456737)
17. Avci Ç. B., Gündüz C., Baran Y., Şahin F., Yilmaz S., Dogan Z. O., Saydam G., Caffeic acid phenethyl ester triggers apoptosis through induction of loss of mitochondrial membrane potential in CCRF-CEM cells. Journal of Cancer Research and Clinical Oncology 2011 137 1 41 47 2-s2.0-78751634252 10.1007/s00432-010-0857-0
18. Akyol S., Ozturk G., Ginis Z., Armutcu F., Yigitoglu M. R., Akyol O., In vivo and in vitro antineoplastic actions of Caffeic acid phenethyl ester (CAPE): therapeutic perspectives. Nutrition and Cancer 2013 65 4 515 526 2-s2.0-84877970486 10.1080/01635581.2013.776693
19. Irmak M. K., Koltuksuz U., Kutlu N. O., Yamurca M., Özyurt H., Karaman A., Akyol Ö., The effect of caffeic acid phenethyl ester on ischemia-reperfusion injury in comparison with α -tocopherol in rat kidneys. Urological Research 2001 29 3 190 193 2-s2.0-0034944281 10.1007/s002400100185 (Pubitemid 32622232)
20. Kirkebøen K. A., Strand O. A., The role of nitric oxide in sepsis-an overview. Acta Anaesthesiologica Scandinavica 1999 43 3 275 288 2-s2.0-0003055186 (Pubitemid 29109473)
21. Walker L. M., Walker P. D., Imam S. Z., Ali S. F., Mayeux P. R., Evidence for peroxynitrite formation in renal ischemia-reperfusion injury: studies with the inducible nitric oxide synthase inhibitor L-N6-(1-iminoethyl)lysine. Journal of Pharmacology and Experimental Therapeutics 2000 295 1 417 422 2-s2.0-0033803122
22. Wangsiripaisan A., Gengaro P. E., Nemenoff R. A., Ling H., Edelstein C. L., Schrier R. W., Effect of nitric oxide donors on renal tubular epithelial cell-matrix adhesion. Kidney International 1999 55 6 2281 2288 2-s2.0-0032989097 10.1046/j.1523-1755.1999.00484.x (Pubitemid 29256482)
23. Ilhan A., Koltuksuz U., Ozen S., Uz E., Ciralik H., Akyol O., The effects of caffeic acid phenethyl ester (CAPE) on spinal cord ischemia/reperfusion injury in rabbits. European Journal of Cardio-Thoracic Surgery 1999 16 4 458 463 2-s2.0-0032854615 10.1016/S1010-7940(99)00246-8 (Pubitemid 29469500)
24. Koltuksuz U., Özen S., Uz E., Aydinç M., Karaman A., Gültek A., Akyol Ö., Harun Gürsoy M., Aydin E., Caffeic acid phenethyl ester prevents intestinal reperfusion injury in rats. Journal of Pediatric Surgery 1999 34 10 1458 1462 2-s2.0-0032741772 10.1016/S0022-3468(99) 90103-3 (Pubitemid 29503800)
25. Winn H. R., Rubio R., Berne R. M., Brain adenosine production in the rat during 60 seconds of ischemia. Circulation Research 1979 45 4 486 492 2-s2.0-0018729531 (Pubitemid 10245190)
26. Joannidis M., Gstraunthaler G., Pfaller W., Xanthine oxidase: evidence against a causative role in renal reperfusion injury. American Journal of Physiology 1990 258 2 F232 F236 2-s2.0-0025304929 (Pubitemid 20100399)
27. Hassan N. A., El-Bassossy H. M., Mahmoud M. F., Fahmy A., Caffeic acid phenethyl ester, a 5-lipoxygenase enzyme inhibitor, alleviates diabetic atherosclerotic manifestations: effect on vascular reactivity and stiffness. Chemico-Biological Interaction 2014 25 28 36
28. Roso N. C., Correa R. R. M., Castiglia Y. M. M., Carvalho L. R., Scatena L. M., De Souza A. V. G., De Oliveira C. C., Vianna P. T. G., Caffeic acid phenethyl ester effects in the kidney during ischemia and reperfusion in rats anesthetized with isoflurane. Transplantation Proceedings 2012 44 5 1211 1213 2-s2.0-84861911674 10.1016/j.transproceed.2012.01.137
29. Nath K. A., Norby S. M., Reactive oxygen species and acute renal failure. American Journal of Medicine 2000 109 8 665 678 2-s2.0-0034562783 10.1016/S0002-9343(00)00612-4
30. Loef B. G., Henning R. H., Epema A. H., Rietman G. W., van Oeveren W., Navis G. J., Ebels T., Effect of dexamethasone on perioperative renal function impairment during cardiac surgery with cardiopulmonary bypass. British Journal of Anaesthesia 2004 93 6 793 798 2-s2.0-9744258712 10.1093/bja/aeh266 (Pubitemid 39585609)
31. Ozer M. K., Parlakpinar H., Vardi N., Cigremis Y., Ucar M., Acet A., Myocardial ischemia/reperfusion-induced oxidative renal damage in rats: protection by caffeic acid phenethyl ester (CAPE). Shock 2005 24 1 97 100 2-s2.0-21744434732 10.1097/01.shk.0000168525.97716.28 (Pubitemid 40946601)
32. Burdmann E. A., Andoh T. F., Yu L., Bennett W. M., Cyclosporine nephrotoxicity. Seminars in Nephrology 2003 23 5 465 476 2-s2.0-0141869674 10.1016/S0270-9295(03)00090-1 (Pubitemid 37176692)
33. Wongmekiat O., Gomonchareonsiri S., Thamprasert K., Caffeic acid phenethyl ester protects against oxidative stress-related renal dysfunction in rats treated with cyclosporin A. Fundamental & Clinical Pharmacology 2011 25 5 619 626 2-s2.0-80052899352 10.1111/j.1472-8206.2010.00884.x
34. Gökçe A., Oktar S., Yönden Z., Aydin M., Ilhan S., Özkan O. V., Davarci M., Yalçinkaya F. R., Protective effect of caffeic acid phenethyl ester on cyclosporine A-induced nephrotoxicity in rats. Renal Failure 2009 31 9 843 847 2-s2.0-71049131591 10.3109/08860220903137517
35. Yilmaz H. R., Sogut S., Ozyurt B., Ozugurlu F., Sahin S., Isik B., Uz E., Ozyurt H., The activities of liver adenosine deaminase, xanthine oxidase, catalase, superoxide dismutase enzymes and the levels of malondialdehyde and nitric oxide after cisplatin toxicity in rats: protective effect of caffeic acid phenethyl ester. Toxicology and Industrial Health 2005 21 3-4 67 73 2-s2.0-20544463473 10.1191/0748233705th216oa (Pubitemid 40839952)
36. Fadilliolu E., Erdoan H., Söüt S., Kuku I., Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats. Journal of Applied Toxicology 2003 23 1 71 74 2-s2.0-0347722762 10.1002/jat.889 (Pubitemid 36157720)
37. Saad S. Y., Najjar T. A., Al-Rikabi A. C., The preventive role of deferoxamine against acute doxorubicin-induced cardiac, renal and hepatic toxicity in rats. Pharmacological Research 2001 43 3 211 218 2-s2.0-0034957066 10.1006/phrs.2000.0769 (Pubitemid 32601427)
38. Jolivet J., Cowan K. H., Curt G. A., Clendeninn N. J., Chabner B. A., The pharmacology and clinical use of methotrexate. The New England Journal of Medicine 1983 309 18 1094 1104 2-s2.0-0020554087 (Pubitemid 13023161)
39. Widemann B. C., Adamson P. C., Understanding and managing methotrexate nephrotoxicity. Oncologist 2006 11 6 694 703 2-s2.0-33745647522 10.1634/theoncologist.11-6-694 (Pubitemid 43967624)
40. Aithal G. P., Hepatotoxicity related to antirheumatic drugs. Nature Reviews Rheumatology 2011 7 3 139 150 2-s2.0-79952446700 10.1038/nrrheum.2010. 214
41. Babiak R. M., Campello A. P., Carnieri E. G., Methotrexate: pentose cycle and oxidative stress. Cell Biochemistry and Function 1998 16 4 283 293 (Pubitemid 28523763)
42. Kintzel P. E., Anticancer drug-induced kidney disorders: incidence, prevention and management. Drug Safety 2001 24 1 19 38 2-s2.0-0035150608 (Pubitemid 32113365)
43. Çakir T., Özkan E., Dulundu E., Topalolu Ü., Şehirli A. Ö., Ercan F., Şener E., Şener G., Caffeic acid phenethyl ester (CAPE) prevents methotrexate-induced hepatorenal oxidative injury in rats. Journal of Pharmacy and Pharmacology 2011 63 12 1566 1571 2-s2.0-80955125184 10.1111/j.2042-7158.2011.01359.x
44. Öktem F., Yilmaz H. R., Ozguner F., Olgar S., Ayata A., Uzar E., Uz E., Methotrexate-induced renal oxidative stress in rats: the role of a novel antioxidant caffeic acid phenethyl ester. Toxicology and Industrial Health 2006 22 6 241 247 2-s2.0-33746878465 10.1191/0748233706th265oa (Pubitemid 44186622)
45. Uz E., Öktem F., Yilmaz H. R., Uzar E., Özgüner F., The activities of purine-catabolizing enzymes and the level of nitric oxide in rat kidneys subjected to methotrexate: protective effect of caffeic acid phenethyl ester. Molecular and Cellular Biochemistry 2005 277 1-2 165 170 2-s2.0-24144500009 10.1007/s11010-005-5875-x (Pubitemid 41236199)
46. Parlakpinar H., Tasdemir S., Polat A., Bay-Karabulut A., Vardi N., Ucar M., Acet A., Protective role of caffeic acid phenethyl ester (CAPE) on gentamicin-induced acute renal toxicity in rats. Toxicology 2005 207 2 169 177 2-s2.0-10444235127 10.1016/j.tox.2004.08.024 (Pubitemid 39642833)
47. Aygün F. Ö., Akçam F. Z., Kaya O., Ceyhan B. M., Sütçü R., Caffeic acid phenethyl ester modulates gentamicin-induced oxidative nephrotoxicity in kidney of rats. Biological Trace Element Research 2012 145 2 211 216 2-s2.0-84857361169 10.1007/s12011-011-9172-0
48. Vardi N., Parlakpinar H., Ozturk F., Acet A., Gentamicin-induced nephrotoxicity and protective effect of caffeic acid phenethyl ester in rats. Fundamental & Clinical Pharmacology 2005 19 2 173 177 2-s2.0-17144386934 10.1111/j.1472-8206.2005.00321.x (Pubitemid 40524116)
49. Levine D. P., Vancomycin: a history. Clinical Infectious Diseases 2006 42 1 S5 S12 2-s2.0-29244437540 10.1086/491709 (Pubitemid 41832060)
50. Farber B. F., Moellering R. C. Jr., Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981. Antimicrobial Agents and Chemotherapy 1983 23 1 138 141 2-s2.0-0020659690 (Pubitemid 13168423)
51. Ingram P. R., Lye D. C., Tambyah P. A., Goh W. P., Tam V. H., Fisher D. A., Risk factors for nephrotoxicity associated with continuous vancomycin infusion in outpatient parenteral antibiotic therapy. Journal of Antimicrobial Chemotherapy 2008 62 1 168 171 2-s2.0-45749083759 10.1093/jac/dkn080 (Pubitemid 351865892)
52. Elyasi S., Khalili H., Dashti-Khavidaki S., Mohammadpour A., Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review. European Journal of Clinical Pharmacology 2012 68 9 1243 1255 2-s2.0-84866628673 10.1007/s00228-012-1259-9
53. Elyasi S., Khalili H., Hatamkhani S., Dashti-Khavidaki S., Prevention of vancomycin induced nephrotoxicity: a review of preclinical data. European Journal of Clinical Pharmacology 2013 69 4 747 754 2-s2.0-84876726800 10.1007/s00228-012-1406-3
54. Ocak S., Gorur S., Hakverdi S., Celik S., Erdogan S., Protective effects of caffeic acid phenethyl ester, vitamin C, vitamin E and N-acetylcysteine on vancomycin-induced nephrotoxicity in rats. Basic and Clinical Pharmacology & Toxicology 2007 100 5 328 333 2-s2.0-34247324695 10.1111/j.1742-7843.2007. 00051.x (Pubitemid 46633475)
55. Öktem F., Arslan M. K., Ozguner F., Candir Ö., Yilmaz H. R., Ciris M., Uz E., In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine. Toxicology 2005 215 3 227 233 2-s2.0-26844514274 10.1016/j.tox.2005.07.009 (Pubitemid 41446325)
56. Parlakpinar H., Tasdemir S., Polat A., Bay-Karabulut A., Vardi N., Ucar M., Yanilmaz M., Kavakli A., Acet A., Protective effect of chelerythrine on gentamicin-induced nephrotoxicity. Cell Biochemistry and Function 2006 24 1 41 48 2-s2.0-31644448165 10.1002/cbf.1182 (Pubitemid 43171006)
57. Naidu M. U. R., Shifow A. A., Kumar K. V., Ratnakar K. S., Ginkgo biloba extract ameliorates gentamicin-induced nephrotoxicity in rats. Phytomedicine 2000 7 3 191 197 2-s2.0-0034094183 (Pubitemid 30415076)
58. Parlakpinar H., Özer M. K., Ucar M., Gaffaroglu M., Vardi N., Koc M., Acet A., Protective effects of caffeic acid phenethyl ester (CAPE) on amikacin-induced nephrotoxicity in rats. Cell Biochemistry and Function 2006 24 4 363 367 2-s2.0-33745977845 10.1002/cbf.1264 (Pubitemid 44065241)
59. Perry H. M. Jr., Thind G. S., Perry E. F., The biology of cadmium. Medical Clinics of North America 1976 60 4 759 769 2-s2.0-0017076450
60. Cuypers A., Plusquin M., Remans T., Jozefczak M., Keunen E., Gielen H., Opdenakker K., Nair A. R., Munters E., Artois T. J., Nawrot T., Vangronsveld J., Smeets K., Cadmium stress: an oxidative challenge. BioMetals 2010 23 5 927 940 2-s2.0-78349308890 10.1007/s10534-010-9329-x
61. Johri N., Jacquillet G., Unwin R., Heavy metal poisoning: the effects of cadmium on the kidney. BioMetals 2010 23 5 783 792 2-s2.0-78349306576 10.1007/s10534-010-9328-y
62. Cannino G., Ferruggia E., Luparello C., Rinaldi A. M., Cadmium and mitochondria. Mitochondrion 2009 9 6 377 384 2-s2.0-70449134646 10.1016/j.mito.2009.08.009
63. Kobroob A., Chattipakorn N., Wongmekiat O., Caffeic acid phenethyl ester ameliorates cadmium-induced kidney mitochondrial injury. Chemico-Biological Interactions 2012 200 1 21 27 2-s2.0-84866855691 10.1016/j.cbi.2012.08.026
64. Gong P., Chen F., Liu X., Gong X., Wang J., Ma Y., Protective effect of caffeic acid phenethyl ester against cadmium-induced renal damage in mice. The Journal of Toxicological Sciences 2012 37 2 415 425 2-s2.0-84859302754 10.2131/jts.37.415
65. Markowitz G. S., Radhakrishnan J., Kambham N., Valeri A. M., Hines W. H., D'Agati V. D., Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy. Journal of the American Society of Nephrology 2000 11 8 1439 1448 2-s2.0-0033914490 (Pubitemid 30483460)
66. Gitlin M., Lithium and the kidney. An updated review. Drug Safety 1999 20 3 231 243 2-s2.0-0033012920 10.2165/00002018-199920030-00004 (Pubitemid 29134898)
67. Oktem F., Ozguner F., Sulak O., Olgar Ş., Akturk O., Yilmaz H. R., Altuntas I., Lithium-induced renal toxicity in rats: protection by a novel antioxidant caffeic acid phenethyl ester. Molecular and Cellular Biochemistry 2005 277 1-2 109 115 2-s2.0-24144501565 10.1007/s11010-005-5426-5 (Pubitemid 41236192)
68. Bozkurt Y., Bozkurt M., Turkçu G., Sancaktutar A. A., Soylemez H., Penbegul N., Atar M., Bodakci M. N., Hatipoglu N. K., Yuksel H., Kibrisli E., Yavuz C., Caffeic acid phenethyl ester protects kidneys against acetylsalicylic acid toxicity in rats. Renal Failure 2012 34 9 1150 1155 2-s2.0-84866386591 10.3109/0886022X.2012.717485
69. Sundari P. N., Wilfred G., Ramakrishna B., Does oxidative protein damage play a role in the pathogenesis of carbon tetrachloride-induced liver injury in the rat? Biochimica et Biophysica Acta 1997 1362 2-3 169 176 2-s2.0-0031593043 10.1016/S0925-4439(97)00065-3 (Pubitemid 28213991)
70. Abraham P., Wilfred G., Cathrine S. P., Oxidative damage to the lipids and proteins of the lungs, testis and kidney of rats during carbon tetrachloride intoxication. Clinica Chimica Acta 1999 289 1-2 177 179 2-s2.0-0032702434 10.1016/S0009-8981(99)00140-0 (Pubitemid 29505210)
71. Ogeturk M., Kus I., Colakoglu N., Zararsiz I., Ilhan N., Sarsilmaz M., Caffeic acid phenethyl ester protects kidneys against carbon tetrachloride toxicity in rats. Journal of Ethnopharmacology 2005 97 2 273 280 2-s2.0-13544249786 10.1016/j.jep.2004.11.019 (Pubitemid 40222029)
72. Huerta C., Castellsague J., Varas-Lorenzo C., García Rodríguez L. A., Nonsteroidal anti-inflammatory drugs and risk of ARF in the general population. American Journal of Kidney Diseases 2005 45 3 531 539 2-s2.0-14844322134 10.1053/j.ajkd.2004.12.005 (Pubitemid 40341332)
73. Murray M. D., Brater D. C., Brater D. C., Renal toxicity of the nonsteroidal anti-inflammatory drugs. Annual Review of Pharmacology and Toxicology 1993 33 435 465 2-s2.0-0027478126 (Pubitemid 23116014)
74. Rifaioglu M. M., Sefil F., Gokce H., Nacar A., Dorum B. A., Davarci M., Protective effects of caffeic acid phenethyl ester on the dose-dependent acute nephrotoxicity with paraquat in a rat model. Environmental Toxicology 2013 10.1002/tox.21915
75. Baliga R., Ueda N., Walker P. D., Shah S. V., Oxidant mechanisms in toxic acute renal failure. Drug Metabolism Reviews 1999 31 4 971 997 2-s2.0-0032725720 10.1081/DMR-100101947
76. Baliga R., Zhang Z., Baliga M., Shah S. V., Evidence for cytochrome P-450 as a source of catalytic iron in myoglobinuric acute renal failure. Kidney International 1996 49 2 362 369 2-s2.0-0030033983 (Pubitemid 26051824)
77. Aydogdu N., Atmaca G., Yalcin O., Batcioglu K., Kaymak K., Effects of caffeic acid phenethyl ester on glycerol-induced acute renal failure in rats. Clinical and Experimental Pharmacology and Physiology 2004 31 9 575 579 2-s2.0-4944262741 10.1111/j.1440-1681.2004.04050.x (Pubitemid 39329758)
78. Orth S. R., Smoking-a renal risk factor. Nephron 2000 86 1 12 26 2-s2.0-0033824272
79. Pekmez H., Ogeturk M., Ozyurt H., Sonmez M. F., Colakoglu N., Kus I., Ameliorative effect of caffeic acid phenethyl ester on histopathological and biochemical changes induced by cigarette smoke in rat kidney. Toxicology and Industrial Health 2010 26 3 175 182 2-s2.0-77950480106 10.1177/0748233710362380
80. Adler S., Huang H., Wolin M. S., Kaminski P. M., Oxidant stress leads to impaired regulation of renal cortical oxygen consumption by nitric oxide in the aging kidney. Journal of the American Society of Nephrology 2004 15 1 52 60 2-s2.0-0347994930 10.1097/01.ASN.0000101032.21097.C5 (Pubitemid 38020697)
81. Radke K. J., Renal physiology series: part 6 of 8. The aging kidney: structure, function, and nursing practice implications. ANNA Journal 1994 21 4 181 191 2-s2.0-0028453732
82. Eşrefolu M., Iraz M., Ateş B., Gül M., Not only melatonin but also caffeic acid phenethyl ester protects kidneys against aging-related oxidative damage in sprague dawley rats. Ultrastructural Pathology 2012 36 4 244 251 2-s2.0-84864534565 10.3109/01913123.2012.679351
83. Yamashita Y., Jeschke M. G., Wolf S. E., Differential expression of hepatocyte growth factor in liver kidney, lung, and spleen following burn in rats. Cytokine 2000 12 9 1293 1298 2-s2.0-0033798309 10.1006/cyto.2000.0719
84. Gurel A., Armutcu F., Hosnuter M., Unalacak M., Kargi E., Altinyazar C., Caffeic acid phenethyl ester improves oxidative organ damage in rat model of thermal trauma. Physiological Research 2004 53 6 675 682 2-s2.0-11244276019 (Pubitemid 40065698)
85. Knave B., Electromagnetic fields and health outcomes. Annals of the Academy of Medicine Singapore 2001 30 5 489 493 2-s2.0-0035465109 (Pubitemid 33612119)
86. Irmak M. K., Fadilliolu E., Güleç M., Erdoan H., Yamurca M., Akyol Ö., Effects of electromagnetic radiation from a cellular telephone on the oxidant and antioxidant levels in rabbits. Cell Biochemistry and Function 2002 20 4 279 283 2-s2.0-0036889201 10.1002/cbf.976 (Pubitemid 35340062)
87. Irmak M. K., Oztas E., Yagmurca M., Fadillioglu E., Bakir B., Effects of electromagnetic radiation from a cellular telephone on epidermal Merkel cells. Journal of Cutaneous Pathology 2003 30 2 135 138 2-s2.0-0037303290 10.1046/j.0303-6987.2003.00002.x (Pubitemid 36384859)
88. Ilhan A., Gurel A., Armutcu F., Kamisli S., Iraz M., Akyol O., Ozen S., Ginkgo biloba prevents mobile phone-induced oxidative stress in rat brain. Clinica Chimica Acta 2004 340 1-2 153 162 2-s2.0-0842281428 10.1016/j.cccn.2003. 10.012 (Pubitemid 38167519)
89. Ozguner F., Oktem F., Armagan A., Yilmaz R., Koyu A., Demirel R., Vural H., Uz E., Comparative analysis of the protective effects of melatonin and caffeic acid phenethyl ester (CAPE) on mobile phone-induced renal impairment in rat. Molecular and Cellular Biochemistry 2005 276 1-2 31 37 2-s2.0-24144434493 10.1007/s11010-005-2734-8 (Pubitemid 41236206)
90. Ozguner M. F., Oktem F., Ayata A., Koyu A., Yilmaz H. R., A novel antioxidant agent caffeic acid phenethyl ester prevents long-term mobile phone exposure-induced renal impairment in rat. Prognostic value of malondialdehyde, N-acetyl- β -d-glucosaminidase and nitric oxide determination. Molecular and Cellular Biochemistry 2005 277 1-2 73 80 2-s2.0-24144466948 10.1007/s11010-005-5074-9 (Pubitemid 41236188)
91. Suhr D., Brummer F., Hulser D. F., Cavitation-generated free radicals during shock wave exposure: investigations with cell-free solutions and suspended cells. Ultrasound in Medicine and Biology 1991 17 8 761 768 2-s2.0-0026331419 10.1016/0301-5629(91)90158-S
92. Morgan T. R., Laudone V. P., Heston W. D. W., Zeitz L., Fair W. R., Free radical production by high energy shock waves-comparison with ionizing irradiation. Journal of Urology 1988 139 1 186 189 2-s2.0-0023878255 (Pubitemid 18050779)
93. Ozguner F., Armagan A., Koyu A., Caliskan S., Koylu H., A novel antioxidant agent caffeic acid phenethyl ester prevents shock wave-induced renal tubular oxidative stress. Urological Research 2005 33 3 239 243 2-s2.0-21244461925 10.1007/s00240-005-0470-x (Pubitemid 40884041)
94. Tepel M., Aspelin P., Lameire N., Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation 2006 113 14 1799 1806 2-s2.0-33646683337 10.1161/CIRCULATIONAHA.105.595090 (Pubitemid 43958473)
95. Colbay M., Yuksel S., Uslan I., Acarturk G., Karaman O., Bas O., Mollaoglu H., Yagmurca M., Ozen O. A., Novel approach for the prevention of contrast nephropathy. Experimental and Toxicologic Pathology 2010 62 1 81 89 2-s2.0-71849109446 10.1016/j.etp.2009.02.119
96. Kudugunti S. K., Vad N. M., Ekogbo E., Moridani M. Y., Efficacy of caffeic acid phenethyl ester (CAPE) in skin B16-F0 melanoma tumor bearing C57BL/6 mice. Investigational New Drugs 2011 29 1 52 62 2-s2.0-79151475189 10.1007/s10637-009-9334-5
97. Chen Y.-J., Liao H.-F., Tsai T.-H., Wang S.-Y., Shiao M.-S., Caffeic acid phenethyl ester preferentially sensitizes CT26 colorectal adenocarcinoma to ionizing radiation without affecting bone marrow radioresponse. International Journal of Radiation Oncology Biology Physics 2005 63 4 1252 1261 2-s2.0-27144442046 10.1016/j.ijrobp.2005.08.001 (Pubitemid 41505307)
98. Ince H., Kandemir E., Bagci C., Gulec M., Akyol O., The effect of caffeic acid phenethyl ester on short-term acute myocardial ischemia. Medical Science Monitor 2006 12 5 BR187 BR193 2-s2.0-33646467705
99. Cagli K., Bagci C., Gulec M., Cengiz B., Akyol O., Sari I., Cavdar S., Pence S., Dinckan H., In vivo effects of caffeic acid phenethyl ester on myocardial ischemia-reperfusion injury and apoptotic changes in rats. Annals of Clinical and Laboratory Science 2005 35 4 440 448 2-s2.0-27644460690 (Pubitemid 41579576)
100. Iraz M., Ozerol E., Gulec M., Tasdemir S., Idiz N., Fadillioglu E., Naziroglu M., Akyol O., Protective effect of caffeic acid phenethyl ester (CAPE) administration on cisplatin-induced oxidative damage to liver in rat. Cell Biochemistry and Function 2006 24 4 357 361 2-s2.0-33746025372 10.1002/cbf.1232 (Pubitemid 44065240)
101. Ilhan A., Iraz M., Gurel A., Armutcu F., Akyol O., Caffeic acid phenethyl ester exerts a neuroprotective effect on CNS against pentylenetetrazol-induced seizures in mice. Neurochemical Research 2004 29 12 2287 2292 2-s2.0-11144276531 10.1007/s11064-004-7038-y (Pubitemid 40036902)
102. Kizilay A., Kalcioglu M. T., Ozerol E., Iraz M., Gulec M., Akyol O., Ozturan O., Caffeic acid phenethyl ester ameliorated ototoxicity induced by cisplatin in rats. Journal of Chemotherapy 2004 16 4 381 387 2-s2.0-3943076441 (Pubitemid 39049889)
103. Ilhan A., Akyol O., Gurel A., Armutcu F., Iraz M., Oztas E., Protective effects of caffeic acid phenethyl ester against experimental allergic encephalomyelitis-induced oxidative stress in rats. Free Radical Biology and Medicine 2004 37 3 386 394 2-s2.0-3042528284 10.1016/j.freeradbiomed.2004.04.022 (Pubitemid 38834004)
104. Özyurt H., Söüt S., Yildirim Z., Kart L., Iraz M., Armutçu F., Temel I., Özen S., Uzun A., Akyol Ö., Inhibitory effect of caffeic acid phenethyl ester on bleomycine-induced lung fibrosis in rats. Clinica Chimica Acta 2004 339 1-2 65 75 2-s2.0-10744221529 10.1016/j.cccn.2003.09.015 (Pubitemid 37542459)
105. Uz E., Söüt S., Sahin S., Var A., Ozyurt H., Güleç M., Akyol O., The protective role of caffeic acid phenethyl ester (CAPE) on testicular tissue after testicular torsion and detorsion. World Journal of Urology 2002 20 4 264 270 2-s2.0-0036730649
106. Koltuksuz U., Mutus H. M., Kutlu R., Ozyurt H., Cetin S., Karaman A., Gurbuz N., Akyol O., Aydin N. E., Effects of caffeic acid phenethyl ester and epidermal growth factor on the development of caustic esophageal stricture in rats. Journal of Pediatric Surgery 2001 36 10 1504 1509 2-s2.0-0034805706 10.1053/jpsu.2001.27032 (Pubitemid 32927656)
107. Koltuksuz U., Irmak M. K., Karaman A., Var E. U. A., Özyurt H., Akyol O., Testicular nitric oxide levels after unilateral testicular torsion/detorsion in rats pretreated with caffeic acid phenethyl ester. Urological Research 2000 28 6 360 363 2-s2.0-0034522399 10.1007/s002400000145 (Pubitemid 32039604)
108. Rifaioglu M. M., Davarci M., Nacar A., Caffeic acid phenethyl ester (CAPE) protects against acute urogenital injury following pneumoperitoneum in the rat. Renal Failure 2014 36 1 98 103
109. Meydan S., Nacar A., Ozturk O. H., The protective effects of caffeic acid phenethyl ester against toluene-induced nephrotoxicity in rats. Toxicology and Industrial Health 2013